217 related articles for article (PubMed ID: 27307499)
41. Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker.
te Vruchte D; Speak AO; Wallom KL; Al Eisa N; Smith DA; Hendriksz CJ; Simmons L; Lachmann RH; Cousins A; Hartung R; Mengel E; Runz H; Beck M; Amraoui Y; Imrie J; Jacklin E; Riddick K; Yanjanin NM; Wassif CA; Rolfs A; Rimmele F; Wright N; Taylor C; Ramaswami U; Cox TM; Hastings C; Jiang X; Sidhu R; Ory DS; Arias B; Jeyakumar M; Sillence DJ; Wraith JE; Porter FD; Cortina-Borja M; Platt FM
J Clin Invest; 2014 Mar; 124(3):1320-8. PubMed ID: 24487591
[TBL] [Abstract][Full Text] [Related]
42. Main Olfactory and Vomeronasal Epithelium Are Differently Affected in Niemann-Pick Disease Type C1.
Witt M; Thiemer R; Meyer A; Schmitt O; Wree A
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424529
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of Two Liver Treatment Strategies in a Mouse Model of Niemann-Pick-Disease Type C1.
Ebner L; Gläser A; Bräuer A; Witt M; Wree A; Rolfs A; Frank M; Vollmar B; Kuhla A
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587349
[TBL] [Abstract][Full Text] [Related]
44. Pharmacokinetics and distribution of 2-hydroxypropyl-β-cyclodextrin following a single intrathecal dose to cats.
Kao ML; Stellar S; Solon E; Lordi A; Kasica N; Swain G; Bagel JH; Gurda BL; Vite CH
J Inherit Metab Dis; 2020 May; 43(3):618-634. PubMed ID: 31707730
[TBL] [Abstract][Full Text] [Related]
45. Long-Term Treatment of Niemann-Pick Type C1 Disease With Intrathecal 2-Hydroxypropyl-β-Cyclodextrin.
Berry-Kravis E; Chin J; Hoffmann A; Winston A; Stoner R; LaGorio L; Friedmann K; Hernandez M; Ory DS; Porter FD; O'Keefe JA
Pediatr Neurol; 2018 Mar; 80():24-34. PubMed ID: 29429782
[TBL] [Abstract][Full Text] [Related]
46. Gender-Specific Effects of Two Treatment Strategies in a Mouse Model of Niemann-Pick Disease Type C1.
Holzmann C; Witt M; Rolfs A; Antipova V; Wree A
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802605
[TBL] [Abstract][Full Text] [Related]
47. Association of Miglustat With Swallowing Outcomes in Niemann-Pick Disease, Type C1.
Solomon BI; Smith AC; Sinaii N; Farhat N; King MC; Machielse L; Porter FD
JAMA Neurol; 2020 Dec; 77(12):1564-1568. PubMed ID: 32897301
[TBL] [Abstract][Full Text] [Related]
48. A validated LC-MS/MS assay for quantification of 24(S)-hydroxycholesterol in plasma and cerebrospinal fluid.
Sidhu R; Jiang H; Farhat NY; Carrillo-Carrasco N; Woolery M; Ottinger E; Porter FD; Schaffer JE; Ory DS; Jiang X
J Lipid Res; 2015 Jun; 56(6):1222-33. PubMed ID: 25866316
[TBL] [Abstract][Full Text] [Related]
49. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life.
Ramirez CM; Liu B; Taylor AM; Repa JJ; Burns DK; Weinberg AG; Turley SD; Dietschy JM
Pediatr Res; 2010 Oct; 68(4):309-15. PubMed ID: 20581737
[TBL] [Abstract][Full Text] [Related]
50. Investigating the Mechanism of Cyclodextrins in the Treatment of Niemann-Pick Disease Type C Using Crosslinked 2-Hydroxypropyl-β-cyclodextrin.
Carradori D; Chen H; Werner B; Shah AS; Leonardi C; Usuelli M; Mezzenga R; Platt F; Leroux JC
Small; 2020 Nov; 16(46):e2004735. PubMed ID: 33079457
[TBL] [Abstract][Full Text] [Related]
51. Collaborative development of 2-hydroxypropyl-β-cyclodextrin for the treatment of Niemann-Pick type C1 disease.
Ottinger EA; Kao ML; Carrillo-Carrasco N; Yanjanin N; Shankar RK; Janssen M; Brewster M; Scott I; Xu X; Cradock J; Terse P; Dehdashti SJ; Marugan J; Zheng W; Portilla L; Hubbs A; Pavan WJ; Heiss J; Vite CH; Walkley SU; Ory DS; Silber SA; Porter FD; Austin CP; McKew JC
Curr Top Med Chem; 2014; 14(3):330-9. PubMed ID: 24283970
[TBL] [Abstract][Full Text] [Related]
52. Correlation of age of onset and clinical severity in Niemann-Pick disease type C1 with lysosomal abnormalities and gene expression.
Baxter LL; Watkins-Chow DE; Johnson NL; Farhat NY; Platt FM; Dale RK; Porter FD; Pavan WJ; Rodriguez-Gil JL
Sci Rep; 2022 Feb; 12(1):2162. PubMed ID: 35140266
[TBL] [Abstract][Full Text] [Related]
53. Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1.
Campbell K; Cawley NX; Luke R; Scott KEJ; Johnson N; Farhat NY; Alexander D; Wassif CA; Li W; Cologna SM; Berry-Kravis E; Do AD; Dale RK; Porter FD
Biomark Res; 2023 Jan; 11(1):14. PubMed ID: 36721240
[TBL] [Abstract][Full Text] [Related]
54. Methyl-β-cyclodextrin restores impaired autophagy flux in Niemann-Pick C1-deficient cells through activation of AMPK.
Dai S; Dulcey AE; Hu X; Wassif CA; Porter FD; Austin CP; Ory DS; Marugan J; Zheng W
Autophagy; 2017 Aug; 13(8):1435-1451. PubMed ID: 28613987
[TBL] [Abstract][Full Text] [Related]
55. Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for
Tseng WC; Loeb HE; Pei W; Tsai-Morris CH; Xu L; Cluzeau CV; Wassif CA; Feldman B; Burgess SM; Pavan WJ; Porter FD
Dis Model Mech; 2018 Aug; 11(9):. PubMed ID: 30135069
[TBL] [Abstract][Full Text] [Related]
56. β-Cyclodextrin-threaded biocleavable polyrotaxanes ameliorate impaired autophagic flux in Niemann-Pick type C disease.
Tamura A; Yui N
J Biol Chem; 2015 Apr; 290(15):9442-54. PubMed ID: 25713067
[TBL] [Abstract][Full Text] [Related]
57. A therapy with miglustat, 2-hydroxypropyl-ß-cyclodextrin and allopregnanolone restores splenic cholesterol homeostasis in Niemann-pick disease type C1.
Neßlauer AM; Gläser A; Gräler M; Engelmann R; Müller-Hilke B; Frank M; Burstein C; Rolfs A; Neidhardt J; Wree A; Witt M; Bräuer AU
Lipids Health Dis; 2019 Jun; 18(1):146. PubMed ID: 31248418
[TBL] [Abstract][Full Text] [Related]
58. Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology.
Cawley NX; Sojka C; Cougnoux A; Lyons AT; Nicoli ER; Wassif CA; Porter FD
PLoS One; 2020; 15(1):e0227829. PubMed ID: 31999726
[TBL] [Abstract][Full Text] [Related]
59. Shortened primary cilium length and dysregulated Sonic hedgehog signaling in Niemann-Pick C1 disease.
Canterini S; Dragotto J; Dardis A; Zampieri S; De Stefano ME; Mangia F; Erickson RP; Fiorenza MT
Hum Mol Genet; 2017 Jun; 26(12):2277-2289. PubMed ID: 28379564
[TBL] [Abstract][Full Text] [Related]
60. Lactose-Appended Hydroxypropyl-β-Cyclodextrin Lowers Cholesterol Accumulation and Alleviates Motor Dysfunction in Niemann-Pick Type C Disease Model Mice.
Nishida T; Yokoyama R; Kubohira Y; Maeda Y; Takeo T; Nakagata N; Takagi H; Ishikura K; Yanagihara K; Misumi S; Kishimoto N; Ishitsuka Y; Kondo Y; Irie T; Soga M; Era T; Onodera R; Higashi T; Motoyama K
ACS Appl Bio Mater; 2022 May; 5(5):2377-2388. PubMed ID: 35506864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
